Is robotic surgery cost-effective: Yes

Daniel Liberman, Quoc Dien Trinh, Claudio Jeldres, Kevin C. Zorn

Research output: Contribution to journalReview articlepeer-review

30 Scopus citations


Purpose of Review: With the expanding use of new technology in the treatment of clinically localized prostate cancer (PCa), the financial burden on the healthcare system and the individual has been important. Robotics offer many potential advantages to the surgeon and the patient. We assessed the potential cost-effectiveness of robotics in urological surgery and performed a comparative cost analysis with respect to other potential treatment modalities. RECENT FINDINGS: The direct and indirect costs of purchasing, maintaining, and operating the robot must be compared to alternatives in treatment of localized PCa. Some expanding technologies including intensity-modulated radiation therapy are significantly more expensive than robotic surgery. Furthermore, the benefits of robotics including decreased length of stay and return to work are considerable and must be measured when evaluating its cost-effectiveness. Summary: Robot-assisted laparoscopic surgery comes at a high cost but can become cost-effective in mostly high-volume centers with high-volume surgeons. The device when utilized to its maximum potential and with eventual market-driven competition can become affordable.

Original languageEnglish (US)
Pages (from-to)61-65
Number of pages5
JournalCurrent Opinion in Urology
Issue number1
StatePublished - Jan 2012


  • comparative analysis
  • cost
  • minimally invasive radical prostatectomy
  • oncology
  • prostatectomy
  • robotics


Dive into the research topics of 'Is robotic surgery cost-effective: Yes'. Together they form a unique fingerprint.

Cite this